DK68876A - Betendelsesmodvirkende midler fremgangsmade til fremstilling heraf og fremgangsmade til behandling af betendelsestilstande ved anvendelse heraf - Google Patents

Betendelsesmodvirkende midler fremgangsmade til fremstilling heraf og fremgangsmade til behandling af betendelsestilstande ved anvendelse heraf

Info

Publication number
DK68876A
DK68876A DK68876*#A DK68876A DK68876A DK 68876 A DK68876 A DK 68876A DK 68876 A DK68876 A DK 68876A DK 68876 A DK68876 A DK 68876A
Authority
DK
Denmark
Prior art keywords
antible
procedures
manufacturing
treatment
immediate conditions
Prior art date
Application number
DK68876*#A
Other languages
Danish (da)
English (en)
Inventor
B J Poulsen
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of DK68876A publication Critical patent/DK68876A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paper (AREA)
DK68876*#A 1975-02-21 1976-02-19 Betendelsesmodvirkende midler fremgangsmade til fremstilling heraf og fremgangsmade til behandling af betendelsestilstande ved anvendelse heraf DK68876A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/551,811 US3934013A (en) 1975-02-21 1975-02-21 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
DK68876A true DK68876A (da) 1976-08-22

Family

ID=24202770

Family Applications (1)

Application Number Title Priority Date Filing Date
DK68876*#A DK68876A (da) 1975-02-21 1976-02-19 Betendelsesmodvirkende midler fremgangsmade til fremstilling heraf og fremgangsmade til behandling af betendelsestilstande ved anvendelse heraf

Country Status (18)

Country Link
US (1) US3934013A (es)
JP (1) JPS6135166B2 (es)
AU (1) AU504748B2 (es)
BE (1) BE838711A (es)
BR (1) BR7600834A (es)
CA (1) CA1067409A (es)
DE (1) DE2605242A1 (es)
DK (1) DK68876A (es)
ES (1) ES445151A1 (es)
FI (1) FI67415C (es)
FR (1) FR2301262A1 (es)
GB (1) GB1502544A (es)
IE (1) IE43655B1 (es)
IL (1) IL48797A (es)
IT (1) IT1066085B (es)
NL (1) NL7601667A (es)
NZ (1) NZ180042A (es)
ZA (1) ZA7671B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK152171B (da) * 1976-10-26 1988-02-08 Scherico Ltd Salve samt salvegrundlag til fremstilling af en saadan

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3864E (es) * 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
IL53617A0 (en) * 1976-12-17 1978-03-10 Scherico Ltd Improvements in or relating to antibiotic formulations
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
US4304765A (en) * 1980-10-14 1981-12-08 Alza Corporation Ocular insert housing steroid in two different therapeutic forms
US4432964A (en) * 1981-08-24 1984-02-21 Alza Corporation Topical composition containing steroid in two forms released independently from polymeric carrier
US4478818A (en) * 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
US4482539A (en) * 1983-05-13 1984-11-13 Schering Corporation Betamethasone dipropionate cream
US4489070A (en) * 1983-05-13 1984-12-18 Schering Corporation Betamethasone dipropionate cream
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
EP0196121A1 (en) * 1985-02-22 1986-10-01 Pera Dr. Visnjic Process for obtaining the preparation for the treatment of the disease psoriasis; drug for the treatment of psoriasis and its application
YU46838B (sh) * 1986-02-14 1994-06-24 Pero Dr. Višnjić Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa
US4780455A (en) * 1985-04-12 1988-10-25 The Trustees Of Columbia University In The City Of New York Lipophilic complexes of pharmacologically active organic compounds
US5002936A (en) * 1985-04-12 1991-03-26 Seymour Lieberman Lipophilic complexes of pharmacologically active inorganic mineral acid esters of organic compounds
US4792556A (en) 1985-09-09 1988-12-20 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
DE3534743A1 (de) * 1985-09-28 1987-04-02 Beiersdorf Ag Hydrocortisondiester enthaltende o/w-creme
US4740372A (en) * 1986-09-17 1988-04-26 Ljubomir Boncic Composition for treating psoriasis vulgaris and a method for its preparation
US5171737A (en) * 1989-03-03 1992-12-15 The Liposome Company, Inc. Emulsions
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles
DE4234225A1 (de) * 1992-10-10 1994-04-14 Roehm Pharma Gmbh Stabile topische Formulierungen mit gutem Wirkstoff-Freisetzungsvermögen enthaltend mindestens ein lipophilisiertes Makrolidantibiotikum
CA2174658C (en) * 1993-10-22 2000-12-19 Harvey Lee Zimmerman Novel composition
AU7510394A (en) * 1994-07-15 1996-02-16 Cohen, Michel Synergistic pharmaceutical compositons containing 16alpha,17alpha-isopropylidenedioxy substituted pregnanes
US5707981A (en) * 1994-07-28 1998-01-13 Psorial, L.L.C. Synergistic pharmaceutical compositions
US7179475B1 (en) 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
WO2000051980A1 (en) 1999-03-05 2000-09-08 The Procter & Gamble Company C16 unsaturated fp-selective prostaglandins analogs
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US6765001B2 (en) * 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
US9623000B2 (en) 2008-07-31 2017-04-18 Dekel Pharmaceuticals Ltd Compositions and methods for treating inflammatory disorders
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) * 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
EP3141246A1 (en) 2009-08-31 2017-03-15 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
ES2391721T3 (es) * 2010-03-01 2012-11-29 Laboratorios Salvat, S.A. Disoluciones acuosas transparentes de acetónido de fluocinolona para el tratamiento de la infamación de oído
US20150258119A1 (en) 2014-03-11 2015-09-17 Promius Pharma, LLC Topical corticosteroid compositions
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
PL409156A1 (pl) 2014-08-11 2016-02-15 Matonis Grzegorz Kompozycja kosmetyczna i/lub farmaceutyczna łagodząca objawy łuszczycy
EP3651753A4 (en) * 2017-07-11 2021-05-05 University Of Miami TOPICAL ACETAMINOPHEN FORMULATIONS FOR ITCH RELIEF
WO2022027041A1 (en) 2020-07-28 2022-02-03 Arcutis Biotherapeutics, Inc. Topical formulation containing jak inhibitor and laureth-4

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3073743A (en) * 1959-07-30 1963-01-15 Upjohn Co Antiinflammatory steroid acetonide compositions and therapy
US3472931A (en) * 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK152171B (da) * 1976-10-26 1988-02-08 Scherico Ltd Salve samt salvegrundlag til fremstilling af en saadan

Also Published As

Publication number Publication date
DE2605242A1 (de) 1976-09-02
IE43655L (en) 1976-08-21
IL48797A (en) 1979-01-31
IT1066085B (it) 1985-03-04
AU1085876A (en) 1977-03-17
GB1502544A (en) 1978-03-01
ZA7671B (en) 1977-08-31
FR2301262B1 (es) 1979-04-06
JPS51110043A (es) 1976-09-29
NZ180042A (en) 1978-07-28
BR7600834A (pt) 1976-09-14
AU504748B2 (en) 1979-10-25
AU1068276A (en) 1977-08-04
FR2301262A1 (fr) 1976-09-17
FI67415B (fi) 1984-11-30
ES445151A1 (es) 1977-05-16
FI67415C (fi) 1985-03-11
NL7601667A (nl) 1976-08-24
IE43655B1 (en) 1981-04-22
US3934013A (en) 1976-01-20
JPS6135166B2 (es) 1986-08-12
BE838711A (fr) 1976-08-19
FI760344A (es) 1976-08-22
IL48797A0 (en) 1976-03-31
CA1067409A (en) 1979-12-04

Similar Documents

Publication Publication Date Title
DK68876A (da) Betendelsesmodvirkende midler fremgangsmade til fremstilling heraf og fremgangsmade til behandling af betendelsestilstande ved anvendelse heraf
DK150092C (da) Engangsble og fremgangsmaade til dens fremstilling
DK449177A (da) Fremgangsmaade til fremstilling af staal
DK49676A (da) Fremgangsmade til fremstilling af hypolipidemiske midler
DK321276A (da) Fremgangsmade til behandling af affald
DK229476A (da) Prostanderivater og fremgangsmade til fremstilling deraf
DK180878A (da) Fremgangsmaade til fremstilling af imidazoaziner og imidazodiaziner
DK242678A (da) Tekstil og fremgangsmaade til fremstilling af samme
DK269175A (da) Fremgangsmade til fremstilling af d-phenylglycinamid og l-phenylglycin
DK398775A (da) Fremgangsmade til fremstilling af derivater af quinoxalin og quinazolin
DK107876A (da) Fremgangsmade til fremstilling af thiocarbamider
DK72476A (da) Fremgangsmade til fremstilling af tetralon- og indanonderivater
DK150676A (da) Fremgangsmade til fremstilling af krystallinsk natrium-o-formyl-cefamandol
DK121776A (da) Fremgangsmade til fremstilling af tricosen-(9) og heneicosen-(9)
DK267078A (da) Fremgangsmaade til fremstilling af n1-glucofuranosid-6-yl-n3-n3-nitrosourinstoffer og derivater deraf
DK177376A (da) Fremgangsmade til fremstilling af elektroniske komponenter og elektroniske komponenter fremstillet ved fremgangsmaden
DK240078A (da) Fremgangsmaade til fremstilling af 19-oxygenerede steroidforbindelser af pregnanraekken og anvendelsen deraf
NO147184C (no) Fremgangsmaate ved fremstilling av alkyltiosulfater og arylalkyltiosulfater.
DK357378A (da) Fremgangsmaade til fremstilling af formlegemer og impraegneringer
DK415576A (da) Fremgangsmade til fremstilling af krystallinsk dipilocarpiniumpamoat
DK399976A (da) Fremgangsmade til fremstilling af aralkylamider
DK228676A (da) Stabile oplosninger af ergotpeptidalkaloider og fremgangsmade til fremstilling deraf
DK461777A (da) Fremgangsmaade og stillads til behandling af overliggende konstruktioner
DK67376A (da) Fremgangsmade til fremstilling af overtrek af metalliske materialer og plastisoler til anvendelse ved fremgangsmaden
TR18836A (tr) Bor-kirec cevherlerinin muamelesine mahsus usul

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment